🧫

ApoE4 Function in Alzheimer's Disease

active
experiment Created: 2026-04-02T10:01:41 By: crosslink-v2 Quality: 67% ✓ SciDEX ID: experiment-exp-wiki-experiments-apoe4-fu
🧫 Experiment Protocol Validationproposed
SUMMARY
# ApoE4 Function in Alzheimer's Disease ## Background and Rationale Apolipoprotein E4 (APOE4) stands as the most potent genetic risk factor for late-onset Alzheimer's disease, conferring a 3-fold increased risk in heterozygotes and up to 15-fold risk in homozygotes compared to the protective APOE3 variant. Despite decades of research, the precise mechanisms by which APOE4 promotes neurodegeneration remain incompletely understood, hampering development of targeted therapeutic interventions for th
METHODOLOGY NOTES
**Phase 1: Animal Model Preparation (Weeks 1-4)** • Generate ApoE4 knockin mice (C57BL/6J-Apoetm1.1(APOE*4)Adiuj/J) and ApoE3 controls (n=40 per genotype) • Age cohorts to 6, 12, and 18 months (n=12-15 per timepoint per genotype) • Maintain on standard chow diet with 12h light/dark cycle • Perform baseline cognitive testing using Morris Water Maze at each timepoint • Collect tail biopsies for genotype confirmation via qPCR **Phase 2: Biochemical Analysis (Weeks 5-8)** • Sacrifice mice at designated timepoints via CO2 asphyxiation followed by cervical dislocation • Rapidly dissect hippocampus and cortex, flash-freeze in liquid nitrogen • Extract soluble and insoluble protein fractions using RIPA buffer with protease inhibitors • Quantify Aβ40 and Aβ42 levels via sandwich ELISA (Invitrogen kits) • Measure tau phosphorylation (pTau181, pTau231) via Western blot • Assess ApoE protein levels and lipidation status via native PAGE **Phase 3: Histopathological Assessment (Weeks 6-10)** • Fix
Metadatasource: {'type': 'manual', 'source_name': 'wiki'
source{'type': 'manual', 'source_name': 'wiki', 'extracted_by': 'backfill_v1', 'extraction_date': '2026-04-16T01:00:16.905039Z'}
summary# ApoE4 Function in Alzheimer's Disease ## Background and Rationale Apolipoprotein E4 (APOE4) stands as the most potent genetic risk factor for late-onset Alzheimer's disease, conferring a 3-fold incr
entities{'genes': ['E4'], 'diseases': ["Alzheimer's Disease"]}
model_systemmouse
_schema_version1
experiment_typevalidation
primary_outcomeValidate ApoE4 Function in Alzheimer's Disease
methodology_notes**Phase 1: Animal Model Preparation (Weeks 1-4)** • Generate ApoE4 knockin mice (C57BL/6J-Apoetm1.1(APOE*4)Adiuj/J) and ApoE3 controls (n=40 per genotype) • Age cohorts to 6, 12, and 18 months (n=12-1
replication_statussingle_study
extraction_metadata{'backfill_at': '2026-04-16T01:00:16.905044', 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'extraction_confidence': 0.4}
📊 Evidence Profile Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
529
Outgoing
490
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.